Technical desiderata for the integration of genomic data into Electronic Health Records
- PMID: 22223081
- PMCID: PMC3328607
- DOI: 10.1016/j.jbi.2011.12.005
Technical desiderata for the integration of genomic data into Electronic Health Records
Abstract
The era of "Personalized Medicine," guided by individual molecular variation in DNA, RNA, expressed proteins and other forms of high volume molecular data brings new requirements and challenges to the design and implementation of Electronic Health Records (EHRs). In this article we describe the characteristics of biomolecular data that differentiate it from other classes of data commonly found in EHRs, enumerate a set of technical desiderata for its management in healthcare settings, and offer a candidate technical approach to its compact and efficient representation in operational systems.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures
References
-
- Human genome: Genomes by the thousand. Nature. 2010 Oct;467:1026–1027. - PubMed
-
- Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science. 2001 Feb 16;291(5507):1304–51. - PubMed
-
- Slodkowska EA, Ross JS. MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients. Expert Rev Mol Diagn. 2009 Jul;9(5):417–22. - PubMed
-
- Roepman P, Horlings HM, Krijgsman O, Kok M, Bueno-de-Mesquita JM, Bender R, Linn SC, Glas AM, van de Vijver MJ. Microarray-based determination of estrogen receptor, progesterone receptor, and HER2 receptor status in breast cancer. Clin Cancer Res. 2009 Nov 15;15(22):7003–11. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources